The footnote that came down

This is a sample post to the Sung Capital newsletter. For full access to the archive and future writeups from Oliver Sung, subscribe here.

Of everything I’ve written in this newsletter, one writeup has drawn more attention than the rest:

The $1bn stake nobody saw

The title for that writeup was probably a touch clickbaity, though I actually was that excited about the setup. I called it one of the most asymmetrical setups I’d seen in a while. An update is now warranted, and therefore some thoughts behind the paywall follow:

This content is for paid subscribers and investors.

Subscribe

Dette indhold er for betalende abonnenter og investorer.

Abonner

Share your idea: Got an exciting off-the-map stock idea? Send it to me. If I end up writing it up, you'll get credit for the idea and a free one-year subscription. Email me at oliver@sungcap.com.
Stocks to your inbox
Join 5,000+ investment professionals and curious stock pickers by subscribing to the newsletter.

Read this next

Net net with 75% upside to NCAV, <2x FCFF, and a 3.2% dividend yield
Today’s stock is a consistently profitable net net.
Update on the share cannibal
Still cheap and misread by the market?
OTC Markets Group
~15x FCF for a monopolistic market operator with infinite returns on capital that could probably grow mid-single digits "forever" is not a bad deal.
Log into your account

By continuing, you agree to our terms of service and acknowledge our privacy policy.

Your client account
Switch language?
Share this content
Stocks to your inbox
Join 5,000+ investment professionals and curious stock pickers by subscribing to the newsletter.
Choose a subscription plan
$500/year
$100/month